All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

502

Reset

502 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • EnobosarmPhase 22 trials

    Veru Inc. · Obesity & Overweight, Mobility Disability, HOMA-IR

  • GV101Phase 22 trials

    Graviton Bioscience Corporation · Friedreich's Ataxia, Weight Management

  • GW906Phase 22 trials

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hypertension

  • HM15275Phase 22 trials

    Hanmi Pharmaceutical Company Limited · Obese, Obesity, Type 2 Diabetes Mellitus

  • HRS-7249Phase 22 trials

    Fujian Shengdi Pharmaceutical Co., Ltd. · Hyperlipidemia

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

  • icovamenibPhase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes

  • IMM01-STEMPhase 22 trials

    Immunis, Inc. · Muscle Performance, Sarcopenic Obesity, Muscle Atrophy

  • IsuzinaxibAPX-115Phase 22 trials

    Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury

  • KDS2010Phase 22 trials

    NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients

  • KHK4951Phase 22 trials

    Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)

  • LAM-001Phase 22 trials

    IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia

  • LT3001 DrugPhase 22 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke

  • LY3549492Phase 22 trials

    Eli Lilly · Obesity, Overweight

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • matching dosagePhase 22 trials

    Hangzhou Sciwind Biosciences Co., Ltd. · Weight Management, Overweight , Obesity, Overweight and/or Obesity

  • MWN109 4Phase 22 trials

    Shanghai Minwei Biotechnology Co., Ltd · Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity

  • NS-863Phase 22 trials

    NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension

  • NT-0796Phase 22 trials

    NodThera Ltd. (a Rezera company) · Obesity and Type 2 Diabetes, Obesity

  • of QLS1410Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma

  • R3R01Phase 22 trials

    River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis

  • RBD5044Phase 22 trials

    Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia

  • REGN7544baloncibartPhase 22 trials

    Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension

  • SGC001Phase 22 trials

    Beijing Sungen Biomedical Technology Co., Ltd · Acute Anterior ST-Segment Elevation Myocardial Infarction, Acute Pancreatitis

  • SRSD107Phase 22 trials

    Sirius Therapeutics Co., Ltd. · Venous Thromboembolism, Coronary Artery Disease (CAD), Peripheral Arterial Disease

  • STP938Phase 22 trials

    Step Pharma, SAS · Lymphoma, B-Cell, Lymphoma, T-Cell, Essential Thrombocythaemia

  • SYH2069group 1, group 2Phase 22 trials

    CSPC Ouyi Pharmaceutical Co., Ltd. · T2DM (Type 2 Diabetes Mellitus), Overweight or Obesity

  • SYH2072Phase 22 trials

    InnovStone Therapeutics Limited · Uncontrolled Hypertension, Resistant Hypertension, Primary Aldosteronism

  • TE-8105 MADPhase 22 trials

    Immunwork, Inc. · Overweight and Obesity

  • TifeglipronRO7795081, CT-996Phase 22 trials

    Roche (Genentech) · Type 2 Diabetes Mellitus, Obesity or Overweight

  • TonlamarsenPhase 22 trials

    Kardigan, Inc. · Hypertension, Acute Severe Hypertension, Hypertensive Emergency

  • TS23Phase 22 trials

    Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism

  • TTI-0102cysteamine-pantetheine disulfidePhase 22 trials

    Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome

  • TX000045Phase 22 trials

    Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary

  • VortosiranPhase 22 trials

    Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)

  • VTX3232Phase 22 trials

    Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • YN001Phase 22 trials

    Beijing Inno Medicine Co., Ltd. · Atherosclerosis, Coronary Artery Disease, Atherosclerotic Cardiovascular Disease

  • ACCG-2671Phase 21 trial

    Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics · Obesity

  • AcmopatideCT-868, RO7795074Phase 21 trial

    Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus

  • AGN-193408Phase 21 trial

    AbbVie · Open-angle Glaucoma, Ocular Hypertension

  • AGP100Phase 21 trial

    Agiana Pharmaceuticals · Catecholaminergic Polymorphic Ventricular Tachycardia

  • ALN-2232Phase 21 trial

    Alnylam Pharmaceuticals · Obesity

  • ALV-100Phase 21 trial

    Alveus Therapeutics, Inc. · Overweight , Obesity, Adults

  • ALXN2350Phase 21 trial

    AstraZeneca · BAG3 Mutation Associated Dilated Cardiomyopathy

  • amsulostatPXS-5505Phase 21 trial

    Syntara · Myelofibrosis, Primary Myelofibrosis (PMF), Post- Essential Thrombocythemia Myelofibrosis

  • AP31969Phase 21 trial

    Acesion Pharma · Atrial Fibrillation (AF)

  • APL-9796Phase 21 trial

    Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension

NewerPage 7 of 11Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.